Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James S. New is active.

Publication


Featured researches published by James S. New.


Annual Reports in Medicinal Chemistry | 1988

Chapter 1. Antipsychotic Agents

James S. New; Katherine S. Takaki

Publisher Summary The emerging technologies of functional and anatomical brain imaging are finding more frequent application in the study of brain structural abnormalities that may underlie the etiology of schizophrenia. New insight into the role of the regional distribution and receptor binding of anti-psychotic agents has been brought by noninvasive radioimaging techniques. Studies of the blood flow in the brains of schizophrenic patients, with positron emission, have revealed an over-activation in the left hemisphere during the performance of a spatial line orientation test. Positron emission tomography (PET) scanning with oxygen-15 (half-life 123 s) in some schizophrenic patients failed to support the hypothesis of reduced blood flow in frontal cortex. Haloperidol-induced dopamine (DA) receptor supersensitivity in schizophrenics appears to be attenuated by concurrent treatment with lithium. The DA hypothesis of schizophrenia has been reviewed in the light of the recent findings. Perioral dyskinesias can be induced acutely in rats by the DA antagonists spiroperidol and sulpiride and by the selective agonist SKF 38393. Attempts to separate the multitude of effects shown by cyproheptadine have included the introduction of nuclear substituents and replacement of a benzene ring by a pyrrole ring. The conformational flexibility was higher for these new pyrrolo-compounds than for the corresponding cyproheptadine derivatives as evidenced from the rates of racemization of the atropisomers. SCH 23390, a selective D 1 antagonist, potently reverses d-amphetamine-induced suppression of two specific DA neuronal firing in the chloral hydrate anesthetized rat. This may be a consequence of a nonselective D 2 antagonist effect of the 5-HT 2 receptor antagonist properties of the molecule. This chapter describes the accumulated experience with depot neuroleptics, such as clopenthixol decanoate and pipotiazine palmitate. The anti-hallucinator effect of chlorpromazine correlates with serum levels of prolactin consistent with the DA hypothesis of schizophrenia. No regional sites pecificity for limbic areas were found with thioridazine or with clozapine. The chapter also discusses the anti-psychotic agents through phenothiazines and related rigid compounds, diphenvlpiperidines and butyrophenones, substituted benzamides, and miscellanious compounds.


Journal of Medicinal Chemistry | 1989

The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity

James S. New; Christopher Wl; Joseph P Yevich; Butler R; Schlemmer Rf; Cam P. VanderMaelen; Joseph A. Cipollina


Archive | 1989

Psychotropic heterobicycloalkylpiperazine derivatives

James S. New; William L. Christopher


Medicinal Research Reviews | 1990

The discovery and development of buspirone: A new approach to the treatment of anxiety

James S. New


Journal of Medicinal Chemistry | 1992

Synthesis and biological characterization of .alpha.-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogs as potential atypical antipsychotic agents

Joseph P Yevich; James S. New; Walter G. Lobeck; Pierre Dextraze; Edith Bernstein; Duncan P. Taylor; Frank D. Yocca; Michael S. Eison; Davis L. Temple


Journal of Medicinal Chemistry | 1983

Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.

Joseph P Yevich; Davis L. Temple; James S. New; Duncan P. Taylor; Leslie A. Riblet


Journal of Medicinal Chemistry | 1988

Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives.

James S. New; Joseph P Yevich; Davis L. Temple; New Kb; Gross Sm; Schlemmer Rf; Michael S. Eison; Duncan P. Taylor; Leslie A. Riblet


Archive | 1986

Antipsychotic cyclic imide derivatives of 2-(4-butylipiperazin-1-yl) pyridines, compositions and use

James S. New; Walter G. Lobeck; Joseph P Yevich


Archive | 1986

Antipsychotic fused-ring pyridinylpiperazine derivatives

James S. New; Joseph P Yevich


Journal of Organic Chemistry | 1989

1,3-Dipolar cycloaddition annulations to the thieno[2,3-d]pyridazine, thieno[3,2-c]pyridine, and thieno[2,3-d]pyrimidine ring systems

James S. New; William L. Christopher; Paul A. Jass

Collaboration


Dive into the James S. New's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Butler R

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge